International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-6 doi: 10.5281/zenodo.10076995
Original Article
A Novel Approach in Interpretation of Blood Indices MCH and MCHC
 ,
Published
Nov. 7, 2023
Abstract

Introduction: Anemia is one of the most pressing public health issue in India. It is not a disease but only a manifestation of underlying disease. Complete blood count is the blood test used to diagnose the prevalence of anemia. Mean corpuscular hemoglobin (MCH) and Mean corpuscular hemoglobin concentration (MCHC) are derived parameters from Hemoglobin, RBC and Hematocrit, which reflects changes in erythrogram. Z Score is standardized Score, measures how many standard deviations a data point is from the mean in a distribution. Here we applied Z Score on MCH and MCHC and analyse the difference between Zmch and Zmchc in different types of Anemia.

Aim and Objective: Utility of Zmch, Zmchc and Z Score analysis in classification of Anemia.

Mathods and Materials: A total of 500 hemograms are studied. Basic statistically formulae using mean and standard deviation are applied to calculate Z Scores. Basically a difference between Zmch and Zmchc are compared in patients having different types of anemia.

Result: Z score is statistically significant in diagnosing Iron deficiency anemia, Megaloblasticanemia, Hemolyticanemia, Anemia of chronic disease and B thalasemia trait.

Conclusion: Hemogram is one of the first investigation ordered in all patients. Detailed analysis of blood indices – Zmch and Zmchc and their difference – Z Score help us to classify anemia and thereby we can directs further actions in patient management and treatment.

Recommended Articles
Loading Image...
Volume-4, Issue-6
Citations
893 Views
385 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved